Cargando…
Correction: Multicentrer study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024251/ https://www.ncbi.nlm.nih.gov/pubmed/35450956 http://dx.doi.org/10.1136/rmdopen-2021-002099corr1 |
Ejemplares similares
-
Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results
por: Van Hoovels, Lieve, et al.
Publicado: (2022) -
Correction: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
por: Kokkonen, Heidi, et al.
Publicado: (2007) -
Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens
por: Fernandes-Cerqueira, Cátia, et al.
Publicado: (2015) -
Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012) -
Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
por: Trier, Nicole H., et al.
Publicado: (2019)